43 results

• Lawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections

  December 30, 2025

  Irvin Jackson

  A Dupixent lawsuit claims a woman developed T-cell lymphoma after just a year of injections, and must now receive lifelong medical monitoring.

• Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis

  December 19, 2025

  Irvin Jackson

  An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers.

• Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027

  December 11, 2025

  Irvin Jackson

  Parties in a Dupixent wrongful death lawsuit met with the presiding judge for the first time this week, indicating the case will be ready for trial by December 6, 2027.

• Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome

  December 5, 2025

  Irvin Jackson

  A Louisiana man was diagnosed with two rare forms of T-cell lymphoma after receiving Dupixent injections for less than two years.

• Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026

  December 2, 2025

  Irvin Jackson

  A federal judge has given the makers of Dupixent until January 7 to respond to a Tennessee woman's wrongful death lawsuit.

• Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit

  October 17, 2025

  Irvin Jackson

  Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward.

• Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link

  October 8, 2025

  Russell Maas

  Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety.

• Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis

  October 2, 2025

  Irvin Jackson

  A Dupixent lawsuit blames the atopic dermatitis drug for causing a woman to develop a deadly form of cancer, which caused her death.

• Dupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks

  August 26, 2025

  Irvin Jackson

  Recent studies warn that the eczema treatment Dupixent appears to significantly increase the risk of cutaneous T-cell lymphoma (CTCL).

• Some Hypertension Drugs May Increase Risk of Eczema in Older Patients, Study Warns

  June 4, 2024

  Martha Garcia

  A new study links the use of blood pressure medications to an increased risk of eczema, with some types of hypertension medications causing a higher risk than others.